Our Alzheimer's Disease Research Center (ADRC) has a major commitment to investigations of aging and age-associated diseases, including illnesses that occur in subjects with Alzheimer's disease (AD) and in older individuals with Down's Syndrome (DS). We believe that genetic factors, abnormalities of protein processing, and age play important roles in the cognitive/memory impairments and in the brain pathology that occur in these individuals. The interface between biological processes and clinical issues (i.e., subtypes of disease, risk and prognostic factors, and relationship of clinical phenotype to brain pathology) are addressed in Cores B and C. At a basic science level, we need more information about the mechanisms that lead to: selective vulnerability of specific neurons; cytoskeletal abnormalities in these cells; the formation of senile plaques; the pathways by which disease spreads; and the occurrence of death of neurons. Moreover, no therapies are available for these disorders. Building upon Core support, Projects 1-6 address some of these issues, focusing on clinical-pathological correlations (Project 2,3,5), the problems of selective vulnerability and the spatial/temporal evolution of pathology (Projects 1,3,4), and molecular mechanisms that lead to neuronal abnormalities characteristic of aging (Projects 1,2), AD (Projects 1,4,5), and DS (Projects 1,3). We believe that these disorders may eventually be amenable to therapeutic approaches, and, in Project 6, we test three biological therapies (i.e., nerve growth factor, peripheral nerve grafts, and neural grafts) designed to influence basal forebrain cholinergic neurons in several animal models. Ultimately, these lines of research should provide new insights into the natural history of the disease, predictors of prognosis, mechanisms of cellular pathology, and, possibly, new approaches to treatment. Finally, our ADRC is committed to the training of young physicians/scientists who represent our best hope for eventually being able to deal with age-associated disorders, such as AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-10
Application #
3104834
Study Section
Aging Review Committee (AGE)
Project Start
1984-09-28
Project End
1994-03-31
Budget Start
1992-04-13
Budget End
1993-03-31
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Eavani, Harini; Habes, Mohamad; Satterthwaite, Theodore D et al. (2018) Heterogeneity of structural and functional imaging patterns of advanced brain aging revealed via machine learning methods. Neurobiol Aging 71:41-50
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75

Showing the most recent 10 out of 830 publications